Accessibility Menu
Emergent Health logo

Emergent Health(OTC) EMGE

Market Cap$42.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-100%
5 Year-100%
1 Year-50%
1 Month+0%
$0.00
+0.00%
+0.00Today
Emergent Health last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-03
Emergent Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-13
1 month+0%USD 0.002026-06-22
3 month+0%USD 0.002026-05-04
Year to date+0%USD 0.002025-12-29
1 year-50%USD 0.002025-08-01
3 year-95.74%USD 0.002023-08-04
5 year-99.85%USD 0.072021-08-04
Since inception-100%USD 18.182007-12-28

Emergent Health Financials at a Glance

Market Cap

$42.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$334.22K

Net Income (TTM)

-$644.42K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

21.49 (High)

Price

$0.00

Volume

309,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

EMGE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Emergent Health

Emergent Health Corp focuses on the creation and distribution of advanced regenerative medicine, alongside a variety of nutraceuticals and plant-derived nutritional supplements. The company aims to enhance health and well-being through innovative products designed to support immune function and overall vitality.

Products and Services
  • Vita-Stim: A nutrient to strengthen the immune system and promote stem cell vitality
  • Neuvitale: Nourishes stem cells and safeguards DNA integrity
  • Hungarest: A dietary aid for appetite regulation
Growth Outlook
  • Emergent Health Corp is positioned in the growing regenerative medicine market
  • Product portfolio expansion aims to meet increasing consumer demand for health supplements
  • Strategic partnerships may enhance distribution channels and market reach
Financial Highlights
  • Recent quarterly revenue of 0 indicates a need for strategic financial management
  • Trailing twelve months (TTM) net income shows a significant loss of -$645,045
  • Current ratio of 0.14 suggests liquidity challenges in meeting short-term obligations
Emergent Health Corp operates in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. The company’s innovative offerings, such as Vita-Stim and Neuvitale, are designed to cater to the growing consumer interest in health and wellness. Despite recent financial challenges, including a reported net income loss, the company is strategically positioned to capitalize on the expanding market for regenerative medicine and nutritional supplements. The focus on product development and potential partnerships may provide avenues for future growth and improved financial performance.
AI Generated • Jul 25, 2026

Industry

Biotechnology

Sector

Health Care

Website

www.emergenthealthcompany.com

Headquarters

King of Prussia, PA 19406, US

EMGE Financials

Key Financial Metrics (TTM)

Gross Margin

63.49%

Operating Margin

-86.10%

Net Income Margin

-99.57%

Return on Equity

90.88%

Return on Capital

-3136.60%

Return on Assets

-305.05%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$42.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

426.95M

Volume

309.00K

Avg. Volume

33.19K

Financials (TTM)

Gross Profit

$171.70K

Operating Income

-$385.59K

EBITDA

-$371.84K

Operating Cash Flow

-$789.89K

Capital Expenditure

$7.00

Free Cash Flow

-$789.89K

Cash & ST Invst.

$2.11K

Total Debt

$2.66M

Emergent Health Performance Analysis

Emergent Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 119,567N/A
20222022-12-31USD 574,613380.6%
20232023-12-31USD 1,635,026184.5%
Emergent Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-40.4%
Q12024-03-3137.8%
Q22024-06-30-200.0%
Q32024-09-30100.0%
Emergent Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.01N/A
20222022-12-31USD -0.0162.0%
20232023-12-31USD -0.00-50.6%
Emergent Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-3168.4%
Q12024-03-31-66.7%
Q22024-06-30120.0%
Q32024-09-30-200.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$42.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$7.12K

N/A

Employees

6

N/A

Net Income

-$64.55K

+91.1%

EBITDA

-$2.78K

+99.6%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$2.11K

-99.4%

Total Debt

$2.66M

+26.4%

Accounts Receivable

$130.98K

+10378.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$2.66M

+26.4%

Return on Assets

-3.05%

N/A

Return on Invested Capital

59.85%

N/A

Free Cash Flow

-$56.47K

-205.6%

Operating Cash Flow

-$56.47K

-205.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QMDTQuick-Med Technologies, Inc.
$0.00+0.00%
THCTTHC Therapeutics, Inc.
$0.00+0.00%
WUHNWuhan General Group (China), Inc.
$0.00+0.00%
REMIRemedent, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About EMGE

What is the current price of Emergent Health?

Emergent Health is trading at $0.00 per share.

What is the 52-week range for Emergent Health?

Over the past 52 weeks, Emergent Health has traded between $0.00 and $0.00.

How much debt does Emergent Health have?

As of the most recent reporting period, Emergent Health reported total debt of $2.66M.

How much cash does Emergent Health have on hand?

Emergent Health reported $233.00 in cash and cash equivalents in its most recent financial results.

What is Emergent Health’s dividend yield?

Emergent Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services